“FDC Limited Timolol Ophthalmic Solution Recall: Cap Stuck in Nozzle.” GovInfoNow, updated August 17, 2026. https://govinfonow.com/recall/32387-fdc-limited-timolol-ophthalmic-solution-recall-cap-stuck-in-nozzle. Based on FDA recall #D-0114-2025 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0114-2025%22&limit=1).
The FDA announced on Dec. 5, 2024, that FDC Limited is recalling Timolol Maleate Ophthalmic Solution USP due to a defective container hazard. The spike of the cap may become lodged in the nozzle, preventing the solution from being dispensed.
The recall involves a defective container where the spike of the cap becomes lodged in the nozzle of the product bottle. This defect makes it impossible to get the solution out of the bottle.
Context
GovInfoNow's records show FDC Limited has issued 10 other recalls since April 25, 2024. Recent similar recalls include the Timolol Ophthalmic Solution 0.5% recall on July 5, 2025, and the Timolol Ophthalmic Solution 10mL recall on April 18, 2025, both citing defective containers with caps stuck in nozzles. Other recent recalls of similar products include the Dorzolamide/Timolol Eye Drops recall (July 22, 2026), the Desmopressin Nasal Spray recall (April 8, 2026), and the TYLENOL Extra Strength 24 Caplets recall (Oct. 21, 2025).
How to tell if you have this one
Check for bottles labeled 'Timolol Maleate Ophthalmic Solution USP 0.25% Sterile 15mL' with lot number 083I006. The product was distributed by Rising Pharmaceuticals Inc in the US.
Brand
FDC Limited
Category
Drug
Based on the official FDA remedy
What to do — step by step
Check Bottle Condition
Inspect if the cap spike is lodged in the nozzle, making it impossible to dispense the solution.
Where it went and when
Where it was distributed
Distributed in New Jersey.
Listed by the agency
Not listed
FDA distribution: “Distributed to one Us Distributor in NJ.” States read from FDA’s own wording; “not listed” means the notice does not name it.
States: New Jersey.
Recall timeline
FDA published this recall 13 days after the firm started it.
1Firm started the recall
2FDA classified it Class II
3Published in FDA’s Enforcement Report
Dates from the agency record only; steps without a date are left out.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
Official source: FDA Recall #D-0114-2025 (December 5, 2024) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0114-2025 to see it in context.
Plain-language summary written by qwen3:4b on August 17, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.